Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries liquid biopharmaceuticals, such as vaccines or protein therapeutics into a particle engineered powder product. The company was incorporated in 2017 and is headquartered in Lund, Sweden.
Stock data | 2024 | Change |
---|---|---|
Price | $0.34089239359357393 | N/A |
Market Cap | $4.71M | N/A |
Shares Outstanding | 13.81M | N/A |
Employees | 9.00 | N/A |